Literature DB >> 21392146

Metabolic bone disease of prematurity and secondary hyperparathyroidism.

Ashish Lothe1, John Sinn, Monique Stone.   

Abstract

AIM: To illustrate, via case histories, the importance of laboratory investigations for the early diagnosis and management of metabolic bone disease (MBD).
METHODS: We report three cases of extreme premature infants with MBD.
RESULTS: These three infants had several risk factors for MBD of prematurity: very low birthweight, delayed enteral feeds, cholestatic liver disease, intolerance of fortification, the use of glucocorticoids and diuretics. Serum alkaline phosphatase and parathyroid hormone (PTH) were elevated despite relatively normal calcium and phosphate levels. These parameters were corrected with additional supplementation of calcium, phosphate and vitamin D.
CONCLUSIONS: Infants born extremely prematurely have significant calcium and phosphate depletion by the time they reach full term compared with the normal fetal accretion rate. This is exacerbated if there is poor tolerability to feeds where extra calcium and phosphate could not be added either by additives or via human milk fortifier. Serum calcium and phosphate levels may be normal despite inadequate intake or stores due to the counter-regulatory effect of PTH. In infants at risk of MBD, testing serum alkaline phosphatase, vitamin D and PTH with calcium and phosphate may assist in the monitoring and management of MBD.
© 2011 The Authors. Journal of Paediatrics and Child Health © 2011 Paediatrics and Child Health Division (Royal Australasian College of Physicians).

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21392146     DOI: 10.1111/j.1440-1754.2011.02019.x

Source DB:  PubMed          Journal:  J Paediatr Child Health        ISSN: 1034-4810            Impact factor:   1.954


  7 in total

1.  Risk factors for metabolic bone disease of prematurity: A meta-analysis.

Authors:  Jie Wang; Qian Zhao; Baochang Chen; Jingfei Sun; Jiayu Huang; Jinfeng Meng; Shangbin Li; Weichen Yan; Changjun Ren; Ling Hao
Journal:  PLoS One       Date:  2022-06-13       Impact factor: 3.752

2.  Parathyroid hormone as a marker for metabolic bone disease of prematurity.

Authors:  A Moreira; L Swischuk; M Malloy; D Mudd; C Blanco; C Geary
Journal:  J Perinatol       Date:  2014-05-29       Impact factor: 2.521

3.  The Clinical and Biochemical Predictors of Bone Mass in Preterm Infants.

Authors:  Justyna Czech-Kowalska; Edyta Czekuc-Kryskiewicz; Pawel Pludowski; Katarzyna Zaniuk; Maciej Jaworski; Anna Łuba; Karolina Grzybowska; Krystyna Piłat; Anna Dobrzanska
Journal:  PLoS One       Date:  2016-11-02       Impact factor: 3.240

4.  Association of Protein and Vitamin D Intake With Biochemical Markers in Premature Osteopenic Infants: A Case-Control Study.

Authors:  Mohamed Mohamed; May Kamleh; Julia Muzzy; Sharon Groh-Wargo; Jalal Abu-Shaweesh
Journal:  Front Pediatr       Date:  2020-11-24       Impact factor: 3.418

Review 5.  Metabolic bone disease of prematurity.

Authors:  Stacy E Rustico; Andrew C Calabria; Samuel J Garber
Journal:  J Clin Transl Endocrinol       Date:  2014-07-04

6.  Risk factors analysis and prevention of metabolic bone disease of prematurity.

Authors:  Wenhao Chen; Changyi Yang; Hanqiang Chen; Baoquan Zhang
Journal:  Medicine (Baltimore)       Date:  2018-10       Impact factor: 1.817

7.  Calcitriol treatment in metabolic bone disease of prematurity with elevated parathyroid hormone: A preliminary study.

Authors:  Stacy E Rustico; Andrea Kelly; Heather M Monk; Andrew C Calabria
Journal:  J Clin Transl Endocrinol       Date:  2014-12-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.